Top of page
Lawyers

Xuelin (Steve) Wang

Lawyers

Filters

JW (Cayman) Therapeutics HK$2.33 billion Hong Kong IPO
Davis Polk advised the underwriters in the initial public offering of JW (Cayman) Therapeutics Co. Ltd on the Hong Kong Stock Exchange and an international offering and listing in reliance…
Shui On Land $500 million high-yield notes offering
Davis Polk advised the joint lead managers in connection with a $500 million Regulation S bonds offering by Shui On Development (Holding) Limited of its 6.150% senior notes due 2024…
Innovent Biologics HK$4.65 billion share placement
Davis Polk advised the sole placing agent for the placement of 56,200,000 new shares and 36,800,000 existing shares in Innovent Biologics, Inc., for an aggregate consideration of…
Genetron Holdings $256 million IPO
Davis Polk advised Genetron Holdings Limited on its SEC-registered initial public offering of 16,000,000 American Depositary Shares. Each ADS represents five ordinary shares. Genetron has…
Back to top